Cargando…
Platelet-activating factor podoplanin: from discovery to drug development
Tumor cell-induced platelet aggregation facilitates hematogenous metastasis by promoting tumor embolization, preventing immunological assaults and shear stress, and the platelet-releasing growth factors support tumor growth and invasion. Podoplanin, also known as Aggrus, is a type I transmembrane mu...
Autores principales: | Takemoto, Ai, Miyata, Kenichi, Fujita, Naoya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557876/ https://www.ncbi.nlm.nih.gov/pubmed/28674748 http://dx.doi.org/10.1007/s10555-017-9672-2 |
Ejemplares similares
-
Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregation
por: Miyata, Kenichi, et al.
Publicado: (2017) -
Targeting a novel domain in podoplanin for inhibiting platelet-mediated tumor metastasis
por: Sekiguchi, Takaya, et al.
Publicado: (2015) -
A critical role of platelet TGF-β release in podoplanin-mediated tumour invasion and metastasis
por: Takemoto, Ai, et al.
Publicado: (2017) -
Suppression of Aggrus/podoplanin-induced platelet aggregation and pulmonary metastasis by a single-chain antibody variable region fragment
por: Miyata, Kenichi, et al.
Publicado: (2014) -
A safety study of newly generated anti-podoplanin-neutralizing antibody in cynomolgus monkey (Macaca fascicularis)
por: Ukaji, Takao, et al.
Publicado: (2018)